All Pharma News
Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc

Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc
BUSINESSWIRE
02 Apr 2024
Share Share
Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.

Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.
GLOBENEWSWIRE
02 Apr 2024
Share Share
Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement

Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement
BUSINESSWIRE
02 Jan 2024
Share Share
In $100M deal, troubled Evofem sells itself to Aditxt

In $100M deal, troubled Evofem sells itself to Aditxt
Eric Sagonowsky FIERCE PHARMA
12 Dec 2023
Share Share
Aditxt, Inc. to Present at 8th Annual Dawson James Conference

Aditxt, Inc. to Present at 8th Annual Dawson James Conference
GLOBENEWSWIRE
06 Oct 2023
Share Share
Aditxt, Inc. Announces Appointment of Ernie Lee as CEO

Aditxt, Inc. Announces Appointment of Ernie Lee as CEO
BUSINESSWIRE
05 Oct 2023
Share Share
Aditxt Announces Participation at H.C. Wainwright 25th Investment Conference

Aditxt Announces Participation at H.C. Wainwright 25th Investment Conference
BUSINESSWIRE
08 Sep 2023
Share Share
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership

Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership
BUSINESSWIRE
20 Apr 2023
Share Share
Aditxt Announces $1.9 M Registered Direct Offering Priced At-The-Marke

Aditxt Announces $1.9 M Registered Direct Offering Priced At-The-Marke
BUSINESSWIRE
20 Apr 2023
Share Share
Aditxt Issues Shareholder Update

Aditxt Issues Shareholder Update
BUSINESSWIRE
17 Apr 2023
Share Share